ACA

Avoro Capital Advisors Portfolio holdings

AUM $5.71B
This Quarter Return
-0.89%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$5.06B
AUM Growth
+$5.06B
Cap. Flow
-$73M
Cap. Flow %
-1.44%
Top 10 Hldgs %
72.91%
Holding
44
New
1
Increased
20
Reduced
5
Closed
4

Top Buys

1
FOLD icon
Amicus Therapeutics
FOLD
$67.7M
2
BCRX icon
BioCryst Pharmaceuticals
BCRX
$48.9M
3
SGEN
Seagen Inc. Common Stock
SGEN
$37.2M
4
RARE icon
Ultragenyx Pharmaceutical
RARE
$31M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
$20.6M

Top Sells

1
XBI icon
SPDR S&P Biotech ETF
XBI
$160M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$120M
3
ACAD icon
Acadia Pharmaceuticals
ACAD
$55.1M
4
PRAX icon
Praxis Precision Medicines
PRAX
$22M
5
UTHR icon
United Therapeutics
UTHR
$14.1M

Sector Composition

1 Healthcare 98.38%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
DSGN icon
26
Design Therapeutics
DSGN
$341M
$31.1M 0.61%
2,222,222
– –
CBAY
27
DELISTED
Cymabay Therapeutics
CBAY
$30.4M 0.6%
10,300,000
– –
KYMR icon
28
Kymera Therapeutics
KYMR
$3.07B
$24.8M 0.49%
1,260,000
+443,500
+54% +$8.73M
WHWK
29
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
$22.5M 0.45%
1,829,402
– –
RNA icon
30
Avidity Biosciences
RNA
$6.11B
$18.9M 0.37%
1,300,000
– –
DICE
31
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$16.7M 0.33%
1,075,000
– –
MRNS
32
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$15.2M 0.3%
3,150,000
– –
NUVL icon
33
Nuvalent
NUVL
$5.66B
$14.2M 0.28%
1,049,471
– –
IOBT icon
34
IO Biotech
IOBT
$114M
$9.6M 0.19%
2,055,883
– –
AMRN
35
Amarin Corp
AMRN
$311M
$8.94M 0.18%
6,000,000
– –
TNGX icon
36
Tango Therapeutics
TNGX
$724M
$7.02M 0.14%
1,550,000
– –
FENC icon
37
Fennec Pharmaceuticals
FENC
$246M
$6.78M 0.13%
1,200,000
– –
RLAY icon
38
Relay Therapeutics
RLAY
$703M
$6.7M 0.13%
+400,000
New +$6.7M
AMTI
39
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$3M 0.06%
1,030,000
– –
GNCA
40
DELISTED
Genocea Biosciences, Inc.
GNCA
$86K ﹤0.01%
5,084,184
– –
ACAD icon
41
Acadia Pharmaceuticals
ACAD
$4.29B
– –
-2,275,000
Closed -$55.1M
ADVM icon
42
Adverum Biotechnologies
ADVM
$67.1M
– –
-6,950,000
Closed -$9.11M
AVDL
43
Avadel Pharmaceuticals
AVDL
$1.41B
– –
-1,670,000
Closed -$11.4M
PRAX icon
44
Praxis Precision Medicines
PRAX
$986M
– –
-2,150,000
Closed -$22M
1
2